Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4439-4444

  Kurdistani, Siavash K ^a   Arizti, Paz ^a   Reimer, Corinne L ^a   Sugrue, Mary M ^b   Aaronson, Stuart A ^b   Lee, Sam W ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; DNA DAMAGE; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; DACTINOMYCIN; DNA DAMAGE; DOXORUBICIN; EPITHELIAL CELLS; FEMALE; GENE LIBRARY; GENES, P53; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MITOMYCIN; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0032188908     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sager, R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc. Natl. Acad. Sci. USA, 94: 952-955, 1997.
2. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Gene expression profiles in normal and cancer cells. Science (Washington DC), 276: 1268-1272, 1997.
3. Michalowitz, D., Halevy, O., and Oren, M. Conditional inhibition of transformation and cell proliferation by a temperature-sensitive mutant of p53. Cell, 62: 671-680, 1990.
4. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
5. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995.
6. Caelles, C., Heimberg, A., and Karin, M. p53-dependent apoptosis in the absence of p53-target genes. Nature (Lond.), 370: 220-223, 1994.
7. Wu, G. S., Burns, T. F., McDonald, E. R., III, Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D., Zhou, J., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and El-Deiry, W. S. KILLER/DK5 is a DNA-damage inducible p53-regulated death receptor gene. Nat. Genet., 17: 141-143, 1997.
8. El-Diery, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
9. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
10. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
11. Waldman, T., Kinzler, K. W., and Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
12. Lee, S. W., Tomasetto, C., and Sager, R. Positive selection of candidate tumor suppressor genes by subtractive hybridization. Proc. Natl. Acad. Sci. USA, 88: 2825-2829, 1991.
13. Band, V., and Sager, R. Distinctive traits of normal and tumor derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA, 86: 1249-1253, 1989.
14. Keyomarsi, K., Sandoval, L., Band, V., and Pardee, A. B. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res., 50: 3602-3609, 1991.
15. Keyomarsi, K., and Pardee, A. B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA, 90: 1112-1116, 1993.
16. Kocher, O., Cheresh, P., and Lee, S. W. Identification and partial characterization of a novel membrane-associated (MAP17) up-regulated in human carcinomas and modulating cell replication and tumor growth. Am. J. Pathol., 149: 493-500, 1996.
17. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of polymerase chain reaction. Science (Washington DC), 257: 967-971, 1992.
18. Welsh, J., Chada, K., Dalal, S., Cheng, R., Ralph, D., and McClelland, M. Arbitrarily primed PCR fingerprinting of RNA. Nucleic Acids Res., 20: 4965-4970, 1992.
19. Kokame, K., Kato., H., and Miyata, T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J. Biol. Chem., 271: 29659-29665, 1996.
20. Lin, T., and Chang, C. Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone. Proc. Natl. Acad. Sci. USA, 94: 4988-4993, 1997.
21. Sugrue, M. M., Shin, D. Y., Lee, S. W., and Aaronson, S. A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA, 94: 9648-9653, 1997.
22. Chen, X., Ko, L. J., Jayaraman, L., and Prives, C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev., 10: 2438-2451, 1996.
23. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
24. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
25. Jarro, H., Rubinfeld, H., Hanoch, T., and Sager, R. Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation. Proc. Natl. Acad. Sci. USA, 94: 3742-3747, 1997.
26. Lenormand, P., Sardet, C., Pages, G., L'Allemain, G., Burnet, A., and Pouyssegur, J. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol., 122: 1079-1088, 1993.
27. Muleris, M., Almeida, M., Gerbault-Seureau, B., Malfoy, B., and Dutrillaux, B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer. 10: 160-170, 1994.
28. Iwabuchi, H., Sakamoto, M., Sakunaga, H., Ma, Y. Y., Carcangiu, M. L., Pinkel, D., Yang-Feng, T. L., and Gray, J. W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res., 55: 6172-6180, 1995.
29. Ambros, P. F., and Karlic, H. I. Chromosomal insertion of human papillomavirus 18 sequences in HeLa cells detected by nonisotopic in situ hybridization and reflection contrast microscopy. Hum. Genet., 77: 251-254, 1987.
30. Lazo, P. A., Gallego, M. I., Ballester, S., and Feduchi, E. Genetic alterations by human papillomavirus in oncogenesis. FEBS Lett., 300: 109-113, 1992.
31. Ahn, J., Ludecke, H. J., Lindow, S., Horton, W. A., Lee, B., Wagner, M. J., Horsthemke, B., and Wells, D. E. Cloning of the putative tumor suppressor gene for hereditary multiple exostoses. Nat. Genet., 11: 137-143, 1995.
32. Hainut, P., Hernandez, T., Robinson, A., Rodriguez-Tome, P., Flores, T., Hollstein, M., Harris, C. C., and Montesano, R. IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res., 26: 205-213, 1998.
33. Hermeking, H., Lengauer, C., Polyak, K., He, T., Zhang, L., Thiagalingam, S., Kinzler, K. W., and Vogelstein, B. 14-3-3s is a p53-regulated inhibitor of G2/M progression. Mol. Cell. 1: 3-11, 1997.
34. Canman, C. E., Gilmer, T. M., Coutts, S. B., and Kastan, M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9: 600-611, 1995.